| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,937,095 | 2,520,789 | 2,789,112 | 3,000,868 | | Cost of Revenue | 1,690,455 | 1,600,568 | 1,871,068 | 1,644,490 | | | Gross Profit | 1,246,640 | 920,221 | 918,044 | 1,356,378 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 165,696 | 185,036 | 153,665 | 725,402 | | Non Recurring | 85,396 |
-
|
-
|
-
| | Others | 280,642 | 260,689 | 257,852 | 274,243 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 800,302 | 474,496 | 506,527 | 356,733 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 195,411 | (9,251) | 37,425 | 41,550 | | Earnings Before Interest And Taxes | 911,633 | 466,614 | 540,825 | 388,641 | | Interest Expense | 171,052 | 144,163 | 137,446 | 159,325 | | Income Before Tax | 740,581 | 322,451 | 403,379 | 229,316 | | Income Tax Expense | 280,415 | 90,640 | 163,046 | 58,742 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 459,724 | 231,811 | 240,333 | 170,574 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 460,166 | 231,811 | 240,333 | 170,574 | | Preferred Stock And Other Adjustments | (4,997) | (4,998) | (4,998) |
-
| | | Net Income Applicable To Common Shares | $455,169 | $226,813 | $235,335 | $170,574 |
|
0.31% Nasdaq 
0.05%
Income Statement
